Current Neuro-Oncology

Volume 12 Number 11
30 November 2010

Home > Publications > Current Neuro-Oncology > Volume 12, Year 2010 > Number 11, 30 November

Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, Wilson KA, Byars A, Sahmoud T, Franz DN.
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.
N Engl J Med. 2010 Nov 4;363(19):1801-11. doi: 10.1056/NEJMoa1001671⍈ PMID: 21047224⍈ Phase 1-2 trial. ⍈

Baldi I, Coureau G, Jaffré A, Gruber A, Ducamp S, Provost D, Lebailly P, Vital A, Loiseau H, Salamon R.
Occupational and residential exposure to electromagnetic fields and risk of brain tumours in adults: A case-control study in gironde, france.
Int J Cancer. 2010 Nov 12. 2011;129(6):1477-84. doi: 10.1002/ijc.25765⍈ PMID: 21792884⍈ Epidemiology analysis. ∟

Byer SJ, Eckert JM, Brossier NM, Clodfelder-Miller BJ, Turk AN, Carroll AJ, Kappes JC, Zinn KR, Prasain JK, Carroll SL.
Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.
Neuro Oncol. 2010 Nov 12. 2011;13(1):28-41. doi: 10.1093/neuonc/noq146⍈. PMID: 21075781⍈. Laboratory investigation. ⍈

Steňo J, Bízik I, Steňo A, Matejčík V.
Craniopharyngiomas in children: how radical should the surgeon be?
Childs Nerv Syst. 2010 Nov 12. 2011;27(1):41-54. doi: 10.1007/s00381-010-1330-8⍈ PMID: 21072523⍈ Case series. ⍈

Alexiou GA, Tsiouris S, Kyritsis AP, Fotakopoulos G, Goussia A, Voulgaris S, Fotopoulos AD.
The Value of 99mTc-Tetrofosmin Brain SPECT in Predicting Survival in Patients with Glioblastoma Multiforme.
J Nucl Med. 2010 Nov 15. 2010;51(12):1923-6. doi: 10.2967/jnumed.110.080929⍈ PMID: 21078797⍈ Prospective study. ⍈

Prados M, Cloughesy T, Samant M, Fang L, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Das A, Friedman HS.
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab.
Neuro Oncol. 2010 Nov 17. 2011;13(1):143-51. doi: 10.1093/neuonc/noq151⍈. PMID: 21084434⍈. Phase 2 trial. ⍈

Desjardins A, Reardon DA, Peters KB, Herndon II JE, Kirkpatrick JP, Friedman HS and Vredenburgh JJ.
Survival And Toxicity Update Of The Phase 2 Trial Of Bevacizumab (Bv) In Combination With Temozolomide (Tmz) And Radiation Therapy (Rt) Followed By Bv, Tmz, And Irinotecan (Cpt-11) For Newly Diagnosed Glioblastoma Multiforme (Gbm) Patients.
Abstracts from the 15th Annual Meeting of the Society for Neuro-Oncology (SNO), November 18–21, 2010, Montreal, Quebec, Canada.
Neuro Oncol. 2010 Nov;12(Suppl_4). EISSN 1523-5866⍈ Phase 2 trial; ⍈

Ogiwara H, Dipatri AJ Jr, Bowman RM, Tomita T, Alden TD.
Diffuse postoperative cerebellar swelling in medulloblastoma: report of two cases.
Childs Nerv Syst. 2010 Nov 20. 2011;27(5):743-7. doi: 10.1007/s00381-010-1343-3⍈ PMID: 21103880⍈ Case series. ⍈

Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, De Maria R.
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.
Nature. 2010 Nov 21;468(7325):824-8⍈. doi: 10.1038/nature09557⍈. PMID: 21102434⍈. Laboratory investigation. ⍈
Erratum in: Nature. 2011 Jan 19;469(7330):432⍈. doi: 10.1038/nature09734⍈. Correction. ⍈
Erratum in: Nature. 2011 Sep 7;477(7363):238⍈. doi: 10.1038/nature10410⍈. Correction. ⍈

Cho YJ, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG, Lau CC, Olson JM, Gilbertson RJ, Gajjar A, Delattre O, Kool M, Ligon K, Meyerson M, Mesirov JP, Pomeroy SL.
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.
J Clin Oncol. 2010 Nov 22. 2011;29(11):1424-30⍈. doi: 10.1200/JCO.2010.28.5148⍈. PMID: 21098324⍈. Laboratory investigation. ⍈

Duda DG, Duyverman AM, Kohno M, Snuderl M, Steller EJ, Fukumura D, Jain RK.
Malignant cells facilitate lung metastasis by bringing their own soil.
Proc Natl Acad Sci USA. 2010 Nov 22. 2010;107(50):21677-82. doi: 10.1073/pnas.1016234107⍈ PMID: 21098274⍈ Laboratory investigation. ⍈

Agar NY, Golby AJ, Ligon KL, Norton I, Mohan V, Wiseman JM, Tannenbaum A, Jolesz FA.
Development of Stereotactic Mass Spectrometry for Brain Tumor Surgery.
Neurosurgery. 2010 Nov 25. 2011;68(2):280-89. doi: 10.1227/NEU.0b013e3181ff9cbb⍈ PMID: 21135749⍈ Clinical tool development. ∟

Anders CK, Deal AM, Miller CR, Khorram C, Meng H, Burrows E, Livasy C, Fritchie K, Ewend MG, Perou CM, Carey LA.
The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
Cancer. 2010 Nov 29. 2011;117(8):1602-11. doi: 10.1002/cncr.25746⍈ PMID: 21472708⍈ Retrospective analysis. ⍈

Hueng DY, Sytwu HK, Huang SM, Chang C, Ma HI.
Isolation and characterization of tumor stem-like cells from human meningiomas.
J Neurooncol. 2010 Nov 30. 2011;104(1):45-53. doi: 10.1007/s11060-010-0469-1⍈ PMID: 21116836⍈ Laboratory investigation. ⍈